Skip to main content
. 2022 Nov-Dec;38(8):2301–2306. doi: 10.12669/pjms.38.8.5506

Table-IV.

Analysis of treatment outcomes and prognosis of the 45 melioidosis patients [n(%)].4

Treatment outcomes and prognosis [n =45] Percentage (%)
Treatment outcomes Cure 23(51.11)
Improvement 15(33.33)
Stable condition 6(13.33)
In-hospital mortality 1(2.22)
Prognosis No recurrence/exacerbation within a year 39(86.67)
Recurrence/exacerbation within 6 months 2(4.44)
Recurrence/exacerbation within a year 3(6.67)
Mortality at a year after discharge 1(2.22)